BUSINESS● LOW1h ago · Sep 28, 2026, 7:16 PM
Lexicon a new overweight at Cantor on optimism for Inpefa in cardiomyopathy
Seeking Alpha Tech · global
Cantor has issued a new "overweight" rating for Lexicon, based on optimism regarding the drug Inpefa for treating cardiomyopathy. This suggests a positive outlook for the company's stock due to a pharmaceutical product.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoPrecision Optics GAAP EPS of -$0.01, revenue of $8.8M beats by $1.65MSeeking Alpha TechBUSINESS22m agoAdecoagro to redeem $235M senior notes earlySeeking Alpha Tech